Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular Tenoxicam After Arthrocentesis for TMJ Osteoarthritis
NCT05497570Phase 1Completed
- Sponsor
- Atatürk University
- Start
- May 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of tenoxicam in temporomandibular joint osteoarthritis (2 arms), sponsored by Atatürk University. Primary endpoints: Pain on Temporomandibular Joint at 6 months, Maximum Mouth Opening at 6 months and 1 more. Started May 2019; status: completed.
02
Drugs
tenoxicam
03
Conditions
temporomandibular joint osteoarthritis
Beyond the preview
Go deeper on NCT05497570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05497570.